• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

免疫检查点抑制剂的内分泌不良反应。

Endocrine adverse effects of immune checkpoint inhibitors.

机构信息

Department of Endocrinology, Auckland City Hospital, Auckland, New Zealand.

出版信息

Intern Med J. 2021 Jul;51(7):1016-1020. doi: 10.1111/imj.14992.

DOI:10.1111/imj.14992
PMID:34278695
Abstract

Immune checkpoint inhibitors are increasingly being utilised as an effective therapy for a variety of cancers. However, they have the potential to cause serious autoimmune toxicities in multiple organ systems termed 'immunotherapy-related adverse events'. Endocrine toxicities are common, can occur well after commencement of therapy and can result in significant morbidity and mortality if not recognised. This makes it important for all physicians, in addition to endocrinologists and oncologists, to understand the nature of these reactions and the general approach to their diagnosis and management. This review aims to provide an overview of the epidemiology, pathophysiology, clinical presentation and management of the endocrine adverse events.

摘要

免疫检查点抑制剂越来越多地被用作多种癌症的有效治疗方法。然而,它们有可能在多个器官系统中引起严重的自身免疫毒性,称为“免疫治疗相关不良事件”。内分泌毒性很常见,在治疗开始后很久才会发生,如果不及时发现,可能会导致严重的发病率和死亡率。这使得所有医生,不仅是内分泌学家和肿瘤学家,都需要了解这些反应的性质以及诊断和管理的一般方法。这篇综述旨在概述内分泌不良事件的流行病学、病理生理学、临床表现和管理。

相似文献

1
Endocrine adverse effects of immune checkpoint inhibitors.免疫检查点抑制剂的内分泌不良反应。
Intern Med J. 2021 Jul;51(7):1016-1020. doi: 10.1111/imj.14992.
2
Endocrine toxicity of immune checkpoint inhibitors: essential crosstalk between endocrinologists and oncologists.免疫检查点抑制剂的内分泌毒性:内分泌科医生与肿瘤科医生之间的重要相互协作
Cancer Med. 2017 Aug;6(8):1923-1929. doi: 10.1002/cam4.1145. Epub 2017 Jul 18.
3
Endocrine toxicities of immune checkpoint inhibitors.免疫检查点抑制剂的内分泌毒性。
Nat Rev Endocrinol. 2021 Jul;17(7):389-399. doi: 10.1038/s41574-021-00484-3. Epub 2021 Apr 19.
4
Endocrine immune-related adverse effects of immune-checkpoint inhibitors.免疫检查点抑制剂的内分泌免疫相关不良反应。
Expert Rev Endocrinol Metab. 2023 Sep-Nov;18(5):441-451. doi: 10.1080/17446651.2023.2256841. Epub 2023 Sep 8.
5
The determinants of very severe immune-related adverse events associated with immune checkpoint inhibitors: A prospective study of the French REISAMIC registry.与免疫检查点抑制剂相关的极重度免疫相关不良事件的决定因素:法国 REISAMIC 注册前瞻性研究。
Eur J Cancer. 2021 Nov;158:217-224. doi: 10.1016/j.ejca.2021.08.048. Epub 2021 Oct 7.
6
Diagnosis, monitoring, and management of adverse events from immune checkpoint inhibitor therapy.免疫检查点抑制剂治疗相关不良事件的诊断、监测和管理。
Curr Oncol. 2020 Apr;27(Suppl 2):S43-S50. doi: 10.3747/co.27.5111. Epub 2020 Apr 1.
7
Cutaneous Adverse Events Associated with Immune Checkpoint Inhibitors: A Review Article.免疫检查点抑制剂相关的皮肤不良反应:一篇综述文章。
Curr Oncol. 2022 Apr 18;29(4):2871-2886. doi: 10.3390/curroncol29040234.
8
Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance.免疫检查点抑制剂的不良反应:流行病学、管理和监测。
Nat Rev Clin Oncol. 2019 Sep;16(9):563-580. doi: 10.1038/s41571-019-0218-0.
9
A Novel Etiology of Hypophysitis: Immune Checkpoint Inhibitors.一种新的垂体炎病因:免疫检查点抑制剂。
Endocrinol Metab Clin North Am. 2020 Sep;49(3):387-399. doi: 10.1016/j.ecl.2020.05.002. Epub 2020 Jul 15.
10
New insight in endocrine-related adverse events associated to immune checkpoint blockade.免疫检查点阻断相关内分泌不良事件的新认识。
Best Pract Res Clin Endocrinol Metab. 2020 Jan;34(1):101370. doi: 10.1016/j.beem.2019.101370. Epub 2019 Dec 11.

引用本文的文献

1
Case report: A case of sintilimab-induced recurrent diabetic ketoacidosis and thyroid dysfunction in a patient with advanced cervical carcinoma.病例报告:晚期宫颈癌患者使用信迪利单抗后复发糖尿病酮症酸中毒和甲状腺功能障碍。
Front Immunol. 2024 Oct 10;15:1405856. doi: 10.3389/fimmu.2024.1405856. eCollection 2024.
2
Late endocrine diseases in survivors of adolescent and young adult cancer in California: a population-based study.加利福尼亚青少年和青年期癌症幸存者的晚期内分泌疾病:一项基于人群的研究。
Br J Cancer. 2024 Apr;130(7):1166-1175. doi: 10.1038/s41416-024-02594-x. Epub 2024 Feb 8.
3
Thyroid dysfunction induced by immune checkpoint inhibitors and tumor progression during neoadjuvant therapy of non‑small cell lung cancer: A case report and literature review.
免疫检查点抑制剂诱导的甲状腺功能障碍与非小细胞肺癌新辅助治疗期间的肿瘤进展:一例报告及文献综述
Oncol Lett. 2023 Sep 29;26(5):496. doi: 10.3892/ol.2023.14083. eCollection 2023 Nov.